For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Genetech, Inc.

USPTO Granted Patents = 98

% Expired Patents = 24.5

Forward Citations = 2,514

Loading Chart...

Loading Chart...

277 inventors (with patents filed for the assignee):

Austin L Gurney (24 out of 719 patents)

Paul J Godowski (23 out of 594 patents)

William I Wood (22 out of 667 patents)

4. Audrey Goddard (21 out of 632 patents)

5. Victoria Smith (11 out of 312 patents)

6. Colin K Watanabe (9 out of 213 patents)

7. Kenneth J Hillan (7 out of 65 patents)

8. Luc Roland Desnoyers (6 out of 143 patents)

9. Napoleone Ferrara (6 out of 106 patents)

10. Margaret Ann Roy (6 out of 56 patents)

11. Daniel Tumas (6 out of 68 patents)

12. P Mickey Williams (5 out of 40 patents)

13. David Botstein (5 out of 60 patents)

14. J Christopher Grimaldi (5 out of 145 patents)

15. Timothy Andrew Stewart (4 out of 61 patents)

Core Competencies:

Cystine Knot Scaffold

VEGF Antibody

Heteroaryl Compounds

Serine Kinase Inhibitors

Anti-HtrA1 Antibodies

Tumor Treatment

Nucleic Acids

EGFR Mutations

Polypeptides

Microwave Deglycosylation

HGF Variants

TRAF Inhibitors

98 patents: Sort by Forward Citations

1. 11407794 - Cystine knot scaffold platform (2022-08-09),

2. 11111291 - Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer (2021-09-07),

3. RE48239 - Heteroaryl pyridone and aza-pyridone compounds (2020-10-05),

4. 10450379 - Method for treating joint damage (2019-10-22),

5. 10421822 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

6. 10239861 - Therapeutic compounds and uses thereof (2019-03-26),

7. 9815904 - Pertuzumab variants and evaluation thereof (2017-11-14),

8. 9625462 - Elisa for VEGF (2017-04-18),

9. 9598481 - Anti-hemagglutinin antibodies and methods of use (2017-03-21),

10. 9409989 - Method for making multispecific antibodies having heteromultimeric and common components (2016-08-09),

11. 9388171 - Serine/threonine kinase inhibitors (2016-07-12),

12. 9315471 - Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof (2016-04-19),

13. 9260425 - Pyrazolo[3,4-c]pyridine compounds and methods of use (2016-02-16),

14. 8975260 - Pyridazinones, method of making, and method of use thereof (2015-03-10),

15. 8952043 - Benzoxepin PI3K inhibitor compounds and methods of use (2015-02-10),

Genentech, Inc., based in South San Francisco, CA, is a pioneering biotechnology company specializing in the development of monoclonal antibodies. The organization focuses on innovative therapeutic solutions targeting various medical conditions, particularly in oncology and ophthalmology. Key technological areas include the Cystine Knot Scaffold, VEGF antibodies, and serine kinase inhibitors, alongside research into anti-HtrA1 antibodies and treatments for tumors associated with EGFR mutations. Genentech is committed to advancing healthcare through cutting-edge biopharmaceuticals.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

98 Patents

#13 in South San Francisco, CA

#890 in California

#3,851 in US

#7,908 in the World

South San Francisco, CA, United States of America

Genetech, Inc.

Forward Citations = 2,514

277 inventors:

Austin L Gurney (24 out of 719 patents)

Paul J Godowski (23 out of 594 patents)

William I Wood (22 out of 667 patents)

4. Audrey Goddard (21 out of 632 patents)

5. Victoria Smith (11 out of 312 patents)

Please report any incorrect information to [email protected]

Loading…